Sex |
Male and female |
Age |
18-44, 45-54, 55-64, 65-74, and ≥ 75 years |
Race/ethnicity |
White, African American, Asian/Pacific Islander, Hispanic (identified as having Spanish/Hispanic surname or of Spanish origin regardless of the category of race/ethnicity), and Native American |
Histology |
Adenocarcinoma, squamous cell carcinoma, and other (other histology or not specified) |
Tumor primary site |
Lower third (C152, C155), middle third (C151, C154), upper third (C150, C153), and overlapping or not specified (C158, C159) |
Tumor grade/differentiation |
Well differentiated (grade 1), moderately differentiated (grade 2), poorly differentiated or undifferentiated (grade 3 or 4), and not determined |
Treatment |
Esophagectomy (partial or total esophagectomy) and radiation therapy (beam radiation or radiation; method or source not specified). Detailed information on surgery of the primary site was not available prior to 1983. Records on chemotherapy were not available in the SEER database. |
Radiation sequence |
No radiation/surgery, neoadjuvant radiation, adjuvant radiation, and intraoperative radiation or unknown |
Marital status at diagnosis |
Not married (including never married, separated, divorced, widowed, and unknown) and married (including common law) |
Stage |
Metastatic (SEER historic stage A code 4) and locoregional (localized or regional corresponding to SEER historic stage A code 1 or 2). |
SEER registry |
17 SEER registry sites (http://seer.cancer.gov/registries/list.html) |
Year of diagnosis |
Three intervals: 1973-1982, 1983-1995, and 1996-2007 |